Expertise in
9
conditions

Uta Merle

Heidelberg, BW, DE 
Expertise in
9
conditions
Heidelberg, BW, DE 

Overview

Uta Merle practices practicing medicine in Heidelberg, Germany.

Ms. Merle is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Hepatocerebral Degeneration, Wilson Disease, COVID-19, Liver Transplant, and Thrombectomy.

She is actively involved in clinical research, co-authoring 184 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Heidelberg, BW, Germany
Other Locations
Salem, BW, Germany
Hamburg, HH, Germany
Wuerzburg, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

RescuE pLAsma eXchange in Severe COVID-19 (RELAX Severe COVID-19)
RescuE pLAsma eXchange in Severe COVID-19 (RELAX Severe COVID-19)
Enrollment Status: Terminated
Publish Date: April 15, 2025
Intervention Type: Other
Study Phase: Not Applicable
Multicentre, Open-Label, Randomised, Two-Arm, Parallel-Group, Superiority Study to Assess Bioavailability and Practicability of Envarsus® Compared With Advagraf® in de Novo Liver Transplant Recipients (EnGraft)
Multicentre, Open-Label, Randomised, Two-Arm, Parallel-Group, Superiority Study to Assess Bioavailability and Practicability of Envarsus® Compared With Advagraf® in de Novo Liver Transplant Recipients (EnGraft)
Enrollment Status: Active_not_recruiting
Publish Date: April 06, 2025
Intervention Type: Drug
Study Phase: Phase 4
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
View 2 Less Clinical Trials

184 Total Publications

Delphi expert consensus on phlebotomy limitations and treatment challenges in HFE-related hemochromatosis.
Delphi expert consensus on phlebotomy limitations and treatment challenges in HFE-related hemochromatosis.
Journal: Clinical hematology international
Published: June 26, 2026

Frequently Asked Questions about Uta Merle

Is Uta Merle a top-rated expert for Hepatocerebral Degeneration?

MediFind is an objective health platform that identifies experts based on real-world data. Uta Merle is classified as an Elite expert for Hepatocerebral Degeneration, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Uta Merle participate in research or clinical trials?

Yes. Uta Merle has published 184 articles and abstracts on conditions like Hepatocerebral Degeneration. You can view a list of Uta Merle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Merle's expertise for a condition
ConditionClose
View All 37 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile